STOCK TITAN

Paysign, Inc. - PAYS STOCK NEWS

Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.

Paysign, Inc. (NASDAQ: PAYS) is a pioneering financial services provider, specializing in prepaid card products and processing services under the Paysign brand. Catering to corporate, consumer, and government applications, Paysign offers a wide array of services including transaction processing, cardholder enrollment, value loading, account management, reporting, and customer service through its proprietary platform.

With a strong footing in the healthcare sector, Paysign develops prepaid card solutions for corporate incentive rewards, expense management, healthcare reimbursement, and pharmaceutical co-pay assistance. The company also provides payroll and general-purpose reloadable cards, along with gift and incentive cards, addressing diverse client needs.

Paysign's recent performance highlights robust revenue growth, driven by its plasma business and the patient affordability segment. The company's plasma revenue continues to be a cornerstone, while its patient affordability offerings show substantial growth, appealing to pharmaceutical companies as a comprehensive solution. As of Q3 2023, Paysign reported a 17% increase in revenue and a 29% rise in net income year-over-year, underscoring its strong operational momentum.

Financially, Paysign remains strong with increasing unrestricted cash and a significant rise in funds on cards. The company maintains a solid balance sheet and is committed to delivering sustainable growth and long-term shareholder value. With over two decades of experience, Paysign continues to innovate with fintech solutions tailored to the healthcare industry, outperforming larger competitors.

Paysign's strategic investments in technology and personnel are expected to drive further growth, with projections for significant increases in both revenue and adjusted EBITDA for the full year of 2024. The company also emphasizes strong customer service, offering 24/7 bilingual support through various channels.

For more information, visit paysign.com.

Rhea-AI Summary
Paysign, Inc. (NASDAQ: PAYS) announces sponsorship of the International Plasma Protein Congress in Athens, Greece. The company has been supporting the Plasma Protein Therapeutics Association for over a decade, advocating for quality and safety in plasma collection and patient access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.27%
Tags
none
-
Rhea-AI Summary
Paysign, Inc. (PAYS) announces Sandy Ortins as the new VP of EFT Services, bringing extensive experience in payment processing. Sandy's background in banking and ACH operations will enhance Paysign's efficiency and growth in transaction volume.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.93%
Tags
none
-
Rhea-AI Summary
Paysign, Inc. (PAYS) announces their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference. The conference aims to address challenges in gene therapy for rare disorders, with Paysign focusing on patient affordability solutions. Matthew Turner, President of Patient Affordability at Paysign, highlights the company's commitment to improving access to gene therapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
Rhea-AI Summary
Paysign, Inc. (PAYS) sponsors the 2024 ACCESS USA Conference, showcasing their commitment to patient affordability and access in the pharmaceutical industry. The conference combines three key events focusing on industry trends, regulatory reforms, and ethical considerations, providing a platform for industry leaders to exchange ideas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Paysign, Inc. (PAYS) will discuss its fourth quarter and full year 2023 earnings on March 26, 2024, offering insights into its prepaid card programs, patient affordability solutions, digital banking services, and payment processing. The earnings call details are provided for participation and registration for financial professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.13%
Tags
conferences earnings
-
Rhea-AI Summary
PAYS reported a 17% increase in total revenues to $12.4 million in Q3 2023, with a net income of $1.1 million and diluted income per share of $0.02. The company added 19 net new plasma donation centers and launched three new patient affordability programs during the quarter, leading to a 13% increase in plasma revenue and a 142% increase in pharma patient affordability revenue. The company also repurchased 75,000 shares of common stock for $150 thousand, ending the quarter with $9.9 million of unrestricted cash and zero debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.53%
Tags
Rhea-AI Summary
Paysign, Inc. to discuss third quarter 2023 earnings on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.57%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
conferences

FAQ

What is the current stock price of Paysign (PAYS)?

The current stock price of Paysign (PAYS) is $3.6 as of October 3, 2024.

What is the market cap of Paysign (PAYS)?

The market cap of Paysign (PAYS) is approximately 191.6M.

What does Paysign, Inc. do?

Paysign, Inc. offers prepaid card products and processing services for corporate, consumer, and government applications.

What are Paysign's main services?

Paysign provides transaction processing, cardholder enrollment, value loading, account management, reporting, and customer service through a proprietary platform.

Which industries does Paysign serve?

Paysign serves various industries including pharmaceutical, healthcare, hospitality, and retail.

How has Paysign performed financially recently?

Paysign has shown strong financial performance with a 17% increase in revenue and a 29% rise in net income year-over-year as of Q3 2023.

What ongoing projects is Paysign involved in?

Paysign is heavily invested in its patient affordability and plasma businesses, with significant growth expected in these areas.

Who are Paysign's customers?

Paysign's customers include major pharmaceutical and healthcare companies, multinational corporations, and government institutions.

What is Paysign's proprietary platform used for?

Paysign's platform is used for managing transaction processing, cardholder enrollment, value loading, account management, and customer service.

How does Paysign support its customers?

Paysign offers 24/7 bilingual customer support through live agents, interactive voice response (IVR), and two-way SMS alerts.

What are some key financial metrics for Paysign?

As of Q3 2023, Paysign reported a 17% increase in revenue and a 29% improvement in net income year-over-year.

What is Paysign's outlook for the future?

Paysign projects continued growth with significant increases in revenue and adjusted EBITDA for 2024, driven by its patient affordability and plasma businesses.

Paysign, Inc.

Nasdaq:PAYS

PAYS Rankings

PAYS Stock Data

191.56M
53.14M
38.86%
29.92%
0.82%
Software - Infrastructure
Services-business Services, Nec
Link
United States of America
HENDERSON